Document Detail

Lipopolysaccharide-induced failure of the gut barrier is site-specific and inhibitable by growth hormone.
MedLine Citation:
PMID:  23340865     Owner:  NLM     Status:  Publisher    
BACKGROUND: Gut barrier failure caused by endotoxemia is a life-threatening problem. The present study aimed to determine whether any specific intestinal site is highly correlated with gut barrier failure, and whether recombinant human growth hormone (rhGH) can ameliorate gut barrier failure in a rat model of endotoxemia. METHODS: Enterostomy tubes were surgically placed in adult male Sprague-Dawley rats three days before induction of endotoxemia by lipopolysaccharide (LPS) injection. Controls received no LPS. Rats were then randomly assigned to receive subcutaneous injections of rhGH (experimental, n = 30) or 0.9 % saline (control, n = 15) at 24, 48, or 72 h after LPS injection. Escherichia coli labeled with green fluorescent protein (GFP) were injected into the intestinal segment of all rats through the enterostomy tubes. The number of GFP-labeled E. coli detected in mesenteric lymph nodes was examined after 96 h. Apoptosis and proliferation rates of intestinal epithelial cells, and intestinal permeability were measured. RESULTS: Endotoxemia led to high mortality, compared with the control group, and rhGH treatment did not improve survival. Intestinal permeability, reflected by translocation rates of GFP-labeled E. coli, and apoptosis rates in the LPS-induced endotoxemia group were higher than those in the non-endotoxemia control group, and the endotoxemia ileum group had the highest rates of both bacterial translocation and apoptosis. The LPS+GH group had less bacterial translocation and apoptosis than the LPS-induced endotoxemia group. In contrast, the proliferation rates were lower in the LPS group compared to the LPS+GH group. CONCLUSIONS: Endotoxemia can induce gut barrier failure in rats, and the ileum is the site of greatest risk. The GH can reduce the incidence of endotoxemia-induced gut barrier failure, but not the associated mortality.
Chao Yue; Wei Wang; Wei-Liang Tian; Qian Huang; Ri-Sheng Zhao; Yun-Zhao Zhao; Qiu-Rong Li; Jie-Shou Li
Related Documents :
21596875 - Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropath...
2593385 - Histamine-induced villous damage in the rat duodenum.
16600315 - The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze...
24760995 - Regulation of the chemosensory control of breathing by kolliker-fuse neurons.
9442455 - Effects on fetal growth of repeated blood collection for toxicokinetics from pregnant r...
1372505 - Verapamil blocks basal and angiotensin ii-induced rna synthesis of rat aortic vascular ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-23
Journal Detail:
Title:  Inflammation research : official journal of the European Histamine Research Society ... [et al.]     Volume:  -     ISSN:  1420-908X     ISO Abbreviation:  Inflamm. Res.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9508160     Medline TA:  Inflamm Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, 305 E Zhong Shan Rd, Nanjing, 210002, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Combinations of cefoxitin plus other ?-lactams are synergistic in vitro against community associated...
Next Document:  Preparation, Characterization, and Bacteriostasis of AgNP-Coated ?-CD Grafting Cellulose Beads.